Bill > SB2997

This bill modifies the Texas Health and Safety Code regarding how controlled substances are scheduled, specifically creating a new process for substances in Schedule I that receive FDA approval. Currently, the commissioner of health must annually establish controlled substance schedules and align them with federal schedules, typically requiring a public hearing and executive approval for changes. The bill adds a new provision that if a Schedule I controlled substance is approved by the FDA under the Federal Food, Drug, and Cosmetic Act and subsequently deleted or rescheduled under federal law, the Texas commissioner must similarly delete or reschedule that substance within 21 days, without requiring the traditional public hearing process. This streamlines the state's scheduling process by allowing more rapid alignment with federal drug scheduling changes, particularly for substances that have received FDA approval. The changes will apply only to controlled substances deleted or rescheduled under federal law on or after the bill's effective date of September 1, 2025, ensuring a clear timeline for implementation.

Health and Social Services

https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=SB2997